TG Therapeutics Initiates Phase 2 Clinical Trial Evaluating BRIUMVI As Maintenance Therapy Following Induction With Efgartigimod In Adult Patients With MG

뉴스 본문을 불러오고 있어요.

TG Therapeutics Initiates Phase 2 Clinical Trial Evaluating BRIUMVI As Maintenance Therapy Following Induction With Efgartigimod In Adult Patients With MG | 웨이프 WAPE

TG Therapeutics Initiates Phase 2 Clinical Trial Evaluating BRIUMVI As Maintenance Therapy Following Induction With Efgartigimod In Adult Patients With MG

기사 요약

관련 종목

댓글 —